Industry Research Reports

Home > Reports > Chemical & Material > Global Roxithromycin API Market Research Report 2025

Global Roxithromycin API Market Research Report 2025

Industry: Chemical & Material

Published Date: 2025-01-16

Pages: 96 Pages

Report ld: 3559120

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Roxithromycin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Roxithromycin(CAS：80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Otto Brandes
Beijing Mesochem Technology
Century Pharmaceuticals
Octavius Pharma Pvt. Ltd
HEC Pharm
Kopran
Alembic Pharmaceuticals Limited
Envee Drugs
Zhejiang Zhenyuan Pharmaceutical
Huangshi Shixing Pharmaceutical
Hanways Chempharm Co., Limited

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Capsules
Granules
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Roxithromycin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Roxithromycin API.

The Roxithromycin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Roxithromycin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Roxithromycin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Roxithromycin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Roxithromycin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Roxithromycin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Roxithromycin API Market Overview

1.1 Product Definition

1.2 Roxithromycin API by Type

1.2.1 Global Roxithromycin API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Above 98 %

1.2.3 Above 99 %

1.3 Roxithromycin API by Application

1.3.1 Global Roxithromycin API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Tablets

1.3.3 Capsules

1.3.4 Granules

1.3.5 Others

1.4 Global Market Growth Prospects

1.4.1 Global Roxithromycin API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Roxithromycin API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Roxithromycin API Production Estimates and Forecasts (2020-2031)

1.4.4 Global Roxithromycin API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Roxithromycin API Production Market Share by Manufacturers (2020-2025)

2.2 Global Roxithromycin API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Roxithromycin API, Industry Ranking, 2023 VS 2024

2.4 Global Roxithromycin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Roxithromycin API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Roxithromycin API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Roxithromycin API, Product Offered and Application

2.8 Global Key Manufacturers of Roxithromycin API, Date of Enter into This Industry

2.9 Roxithromycin API Market Competitive Situation and Trends

2.9.1 Roxithromycin API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Roxithromycin API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Roxithromycin API Production by Region

3.1 Global Roxithromycin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Roxithromycin API Production Value by Region (2020-2031)

3.2.1 Global Roxithromycin API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Roxithromycin API by Region (2026-2031)

3.3 Global Roxithromycin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Roxithromycin API Production Volume by Region (2020-2031)

3.4.1 Global Roxithromycin API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Roxithromycin API by Region (2026-2031)

3.5 Global Roxithromycin API Market Price Analysis by Region (2020-2025)

3.6 Global Roxithromycin API Production and Value, Year-over-Year Growth

3.6.1 Europe Roxithromycin API Production Value Estimates and Forecasts (2020-2031)

3.6.2 China Roxithromycin API Production Value Estimates and Forecasts (2020-2031)

3.6.3 India Roxithromycin API Production Value Estimates and Forecasts (2020-2031)

4 Roxithromycin API Consumption by Region

4.1 Global Roxithromycin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Roxithromycin API Consumption by Region (2020-2031)

4.2.1 Global Roxithromycin API Consumption by Region (2020-2025)

4.2.2 Global Roxithromycin API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Roxithromycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Roxithromycin API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Roxithromycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Roxithromycin API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Roxithromycin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Roxithromycin API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Roxithromycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Roxithromycin API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Roxithromycin API Production by Type (2020-2031)

5.1.1 Global Roxithromycin API Production by Type (2020-2025)

5.1.2 Global Roxithromycin API Production by Type (2026-2031)

5.1.3 Global Roxithromycin API Production Market Share by Type (2020-2031)

5.2 Global Roxithromycin API Production Value by Type (2020-2031)

5.2.1 Global Roxithromycin API Production Value by Type (2020-2025)

5.2.2 Global Roxithromycin API Production Value by Type (2026-2031)

5.2.3 Global Roxithromycin API Production Value Market Share by Type (2020-2031)

5.3 Global Roxithromycin API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Roxithromycin API Production by Application (2020-2031)

6.1.1 Global Roxithromycin API Production by Application (2020-2025)

6.1.2 Global Roxithromycin API Production by Application (2026-2031)

6.1.3 Global Roxithromycin API Production Market Share by Application (2020-2031)

6.2 Global Roxithromycin API Production Value by Application (2020-2031)

6.2.1 Global Roxithromycin API Production Value by Application (2020-2025)

6.2.2 Global Roxithromycin API Production Value by Application (2026-2031)

6.2.3 Global Roxithromycin API Production Value Market Share by Application (2020-2031)

6.3 Global Roxithromycin API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Otto Brandes

7.1.1 Otto Brandes Roxithromycin API Company Information

7.1.2 Otto Brandes Roxithromycin API Product Portfolio

7.1.3 Otto Brandes Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Otto Brandes Main Business and Markets Served

7.1.5 Otto Brandes Recent Developments/Updates

7.2 Beijing Mesochem Technology

7.2.1 Beijing Mesochem Technology Roxithromycin API Company Information

7.2.2 Beijing Mesochem Technology Roxithromycin API Product Portfolio

7.2.3 Beijing Mesochem Technology Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Beijing Mesochem Technology Main Business and Markets Served

7.2.5 Beijing Mesochem Technology Recent Developments/Updates

7.3 Century Pharmaceuticals

7.3.1 Century Pharmaceuticals Roxithromycin API Company Information

7.3.2 Century Pharmaceuticals Roxithromycin API Product Portfolio

7.3.3 Century Pharmaceuticals Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Century Pharmaceuticals Main Business and Markets Served

7.3.5 Century Pharmaceuticals Recent Developments/Updates

7.4 Octavius Pharma Pvt. Ltd

7.4.1 Octavius Pharma Pvt. Ltd Roxithromycin API Company Information

7.4.2 Octavius Pharma Pvt. Ltd Roxithromycin API Product Portfolio

7.4.3 Octavius Pharma Pvt. Ltd Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Octavius Pharma Pvt. Ltd Main Business and Markets Served

7.4.5 Octavius Pharma Pvt. Ltd Recent Developments/Updates

7.5 HEC Pharm

7.5.1 HEC Pharm Roxithromycin API Company Information

7.5.2 HEC Pharm Roxithromycin API Product Portfolio

7.5.3 HEC Pharm Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 HEC Pharm Main Business and Markets Served

7.5.5 HEC Pharm Recent Developments/Updates

7.6 Kopran

7.6.1 Kopran Roxithromycin API Company Information

7.6.2 Kopran Roxithromycin API Product Portfolio

7.6.3 Kopran Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Kopran Main Business and Markets Served

7.6.5 Kopran Recent Developments/Updates

7.7 Alembic Pharmaceuticals Limited

7.7.1 Alembic Pharmaceuticals Limited Roxithromycin API Company Information

7.7.2 Alembic Pharmaceuticals Limited Roxithromycin API Product Portfolio

7.7.3 Alembic Pharmaceuticals Limited Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Alembic Pharmaceuticals Limited Main Business and Markets Served

7.7.5 Alembic Pharmaceuticals Limited Recent Developments/Updates

7.8 Envee Drugs

7.8.1 Envee Drugs Roxithromycin API Company Information

7.8.2 Envee Drugs Roxithromycin API Product Portfolio

7.8.3 Envee Drugs Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Envee Drugs Main Business and Markets Served

7.8.5 Envee Drugs Recent Developments/Updates

7.9 Zhejiang Zhenyuan Pharmaceutical

7.9.1 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Company Information

7.9.2 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Product Portfolio

7.9.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Zhejiang Zhenyuan Pharmaceutical Main Business and Markets Served

7.9.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments/Updates

7.10 Huangshi Shixing Pharmaceutical

7.10.1 Huangshi Shixing Pharmaceutical Roxithromycin API Company Information

7.10.2 Huangshi Shixing Pharmaceutical Roxithromycin API Product Portfolio

7.10.3 Huangshi Shixing Pharmaceutical Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Huangshi Shixing Pharmaceutical Main Business and Markets Served

7.10.5 Huangshi Shixing Pharmaceutical Recent Developments/Updates

7.11 Hanways Chempharm Co., Limited

7.11.1 Hanways Chempharm Co., Limited Roxithromycin API Company Information

7.11.2 Hanways Chempharm Co., Limited Roxithromycin API Product Portfolio

7.11.3 Hanways Chempharm Co., Limited Roxithromycin API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Hanways Chempharm Co., Limited Main Business and Markets Served

7.11.5 Hanways Chempharm Co., Limited Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Roxithromycin API Industry Chain Analysis

8.2 Roxithromycin API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Roxithromycin API Production Mode & Process Analysis

8.4 Roxithromycin API Sales and Marketing

8.4.1 Roxithromycin API Sales Channels

8.4.2 Roxithromycin API Distributors

8.5 Roxithromycin API Customer Analysis

9 Roxithromycin API Market Dynamics

9.1 Roxithromycin API Industry Trends

9.2 Roxithromycin API Market Drivers

9.3 Roxithromycin API Market Challenges

9.4 Roxithromycin API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Roxithromycin API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Roxithromycin API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Roxithromycin API Production Capacity (Kg) by Manufacturers in 2024

Table 4. Global Roxithromycin API Production by Manufacturers (2020-2025) & (Kg)

Table 5. Global Roxithromycin API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Roxithromycin API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Roxithromycin API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Roxithromycin API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Roxithromycin API as of 2024)

Table 10. Global Market Roxithromycin API Average Price by Manufacturers (US$/Kg) & (2020-2025)

Table 11. Global Key Manufacturers of Roxithromycin API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Roxithromycin API, Product Offered and Application

Table 13. Global Key Manufacturers of Roxithromycin API, Date of Enter into This Industry

Table 14. Global Roxithromycin API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Roxithromycin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Roxithromycin API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Roxithromycin API Production Value Market Share by Region (2020-2025)

Table 19. Global Roxithromycin API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Roxithromycin API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Roxithromycin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Roxithromycin API Production (Kg) by Region (2020-2025)

Table 23. Global Roxithromycin API Production Market Share by Region (2020-2025)

Table 24. Global Roxithromycin API Production (Kg) Forecast by Region (2026-2031)

Table 25. Global Roxithromycin API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Roxithromycin API Market Average Price (US$/Kg) by Region (2020-2025)

Table 27. Global Roxithromycin API Market Average Price (US$/Kg) by Region (2026-2031)

Table 28. Global Roxithromycin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)

Table 29. Global Roxithromycin API Consumption by Region (2020-2025) & (Kg)

Table 30. Global Roxithromycin API Consumption Market Share by Region (2020-2025)

Table 31. Global Roxithromycin API Forecasted Consumption by Region (2026-2031) & (Kg)

Table 32. Global Roxithromycin API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Roxithromycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 34. North America Roxithromycin API Consumption by Country (2020-2025) & (Kg)

Table 35. North America Roxithromycin API Consumption by Country (2026-2031) & (Kg)

Table 36. Europe Roxithromycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 37. Europe Roxithromycin API Consumption by Country (2020-2025) & (Kg)

Table 38. Europe Roxithromycin API Consumption by Country (2026-2031) & (Kg)

Table 39. Asia Pacific Roxithromycin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)

Table 40. Asia Pacific Roxithromycin API Consumption by Region (2020-2025) & (Kg)

Table 41. Asia Pacific Roxithromycin API Consumption by Region (2026-2031) & (Kg)

Table 42. Latin America, Middle East & Africa Roxithromycin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 43. Latin America, Middle East & Africa Roxithromycin API Consumption by Country (2020-2025) & (Kg)

Table 44. Latin America, Middle East & Africa Roxithromycin API Consumption by Country (2026-2031) & (Kg)

Table 45. Global Roxithromycin API Production (Kg) by Type (2020-2025)

Table 46. Global Roxithromycin API Production (Kg) by Type (2026-2031)

Table 47. Global Roxithromycin API Production Market Share by Type (2020-2025)

Table 48. Global Roxithromycin API Production Market Share by Type (2026-2031)

Table 49. Global Roxithromycin API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Roxithromycin API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Roxithromycin API Production Value Market Share by Type (2020-2025)

Table 52. Global Roxithromycin API Production Value Market Share by Type (2026-2031)

Table 53. Global Roxithromycin API Price (US$/Kg) by Type (2020-2025)

Table 54. Global Roxithromycin API Price (US$/Kg) by Type (2026-2031)

Table 55. Global Roxithromycin API Production (Kg) by Application (2020-2025)

Table 56. Global Roxithromycin API Production (Kg) by Application (2026-2031)

Table 57. Global Roxithromycin API Production Market Share by Application (2020-2025)

Table 58. Global Roxithromycin API Production Market Share by Application (2026-2031)

Table 59. Global Roxithromycin API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Roxithromycin API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Roxithromycin API Production Value Market Share by Application (2020-2025)

Table 62. Global Roxithromycin API Production Value Market Share by Application (2026-2031)

Table 63. Global Roxithromycin API Price (US$/Kg) by Application (2020-2025)

Table 64. Global Roxithromycin API Price (US$/Kg) by Application (2026-2031)

Table 65. Otto Brandes Roxithromycin API Company Information

Table 66. Otto Brandes Roxithromycin API Specification and Application

Table 67. Otto Brandes Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 68. Otto Brandes Main Business and Markets Served

Table 69. Otto Brandes Recent Developments/Updates

Table 70. Beijing Mesochem Technology Roxithromycin API Company Information

Table 71. Beijing Mesochem Technology Roxithromycin API Specification and Application

Table 72. Beijing Mesochem Technology Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Beijing Mesochem Technology Main Business and Markets Served

Table 74. Beijing Mesochem Technology Recent Developments/Updates

Table 75. Century Pharmaceuticals Roxithromycin API Company Information

Table 76. Century Pharmaceuticals Roxithromycin API Specification and Application

Table 77. Century Pharmaceuticals Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. Century Pharmaceuticals Main Business and Markets Served

Table 79. Century Pharmaceuticals Recent Developments/Updates

Table 80. Octavius Pharma Pvt. Ltd Roxithromycin API Company Information

Table 81. Octavius Pharma Pvt. Ltd Roxithromycin API Specification and Application

Table 82. Octavius Pharma Pvt. Ltd Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Octavius Pharma Pvt. Ltd Main Business and Markets Served

Table 84. Octavius Pharma Pvt. Ltd Recent Developments/Updates

Table 85. HEC Pharm Roxithromycin API Company Information

Table 86. HEC Pharm Roxithromycin API Specification and Application

Table 87. HEC Pharm Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. HEC Pharm Main Business and Markets Served

Table 89. HEC Pharm Recent Developments/Updates

Table 90. Kopran Roxithromycin API Company Information

Table 91. Kopran Roxithromycin API Specification and Application

Table 92. Kopran Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. Kopran Main Business and Markets Served

Table 94. Kopran Recent Developments/Updates

Table 95. Alembic Pharmaceuticals Limited Roxithromycin API Company Information

Table 96. Alembic Pharmaceuticals Limited Roxithromycin API Specification and Application

Table 97. Alembic Pharmaceuticals Limited Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Alembic Pharmaceuticals Limited Main Business and Markets Served

Table 99. Alembic Pharmaceuticals Limited Recent Developments/Updates

Table 100. Envee Drugs Roxithromycin API Company Information

Table 101. Envee Drugs Roxithromycin API Specification and Application

Table 102. Envee Drugs Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. Envee Drugs Main Business and Markets Served

Table 104. Envee Drugs Recent Developments/Updates

Table 105. Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Company Information

Table 106. Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Specification and Application

Table 107. Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Zhejiang Zhenyuan Pharmaceutical Main Business and Markets Served

Table 109. Zhejiang Zhenyuan Pharmaceutical Recent Developments/Updates

Table 110. Huangshi Shixing Pharmaceutical Roxithromycin API Company Information

Table 111. Huangshi Shixing Pharmaceutical Roxithromycin API Specification and Application

Table 112. Huangshi Shixing Pharmaceutical Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. Huangshi Shixing Pharmaceutical Main Business and Markets Served

Table 114. Huangshi Shixing Pharmaceutical Recent Developments/Updates

Table 115. Hanways Chempharm Co., Limited Roxithromycin API Company Information

Table 116. Hanways Chempharm Co., Limited Roxithromycin API Specification and Application

Table 117. Hanways Chempharm Co., Limited Roxithromycin API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Hanways Chempharm Co., Limited Main Business and Markets Served

Table 119. Hanways Chempharm Co., Limited Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Roxithromycin API Distributors List

Table 123. Roxithromycin API Customers List

Table 124. Roxithromycin API Market Trends

Table 125. Roxithromycin API Market Drivers

Table 126. Roxithromycin API Market Challenges

Table 127. Roxithromycin API Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Roxithromycin API

Figure 2. Global Roxithromycin API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Roxithromycin API Market Share by Type: 2024 VS 2031

Figure 4. Above 98 % Product Picture

Figure 5. Above 99 % Product Picture

Figure 6. Global Roxithromycin API Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Roxithromycin API Market Share by Application: 2024 VS 2031

Figure 8. Tablets

Figure 9. Capsules

Figure 10. Granules

Figure 11. Others

Figure 12. Global Roxithromycin API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Roxithromycin API Production Value (US$ Million) & (2020-2031)

Figure 14. Global Roxithromycin API Production Capacity (Kg) & (2020-2031)

Figure 15. Global Roxithromycin API Production (Kg) & (2020-2031)

Figure 16. Global Roxithromycin API Average Price (US$/Kg) & (2020-2031)

Figure 17. Roxithromycin API Report Years Considered

Figure 18. Roxithromycin API Production Share by Manufacturers in 2024

Figure 19. Global Roxithromycin API Production Value Share by Manufacturers (2024)

Figure 20. Roxithromycin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. The Global 5 and 10 Largest Players: Market Share by Roxithromycin API Revenue in 2024

Figure 22. Global Roxithromycin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 23. Global Roxithromycin API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. Global Roxithromycin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)

Figure 25. Global Roxithromycin API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 26. Europe Roxithromycin API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. China Roxithromycin API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. India Roxithromycin API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Global Roxithromycin API Consumption by Region: 2020 VS 2024 VS 2031 (Kg)

Figure 30. Global Roxithromycin API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 31. North America Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 32. North America Roxithromycin API Consumption Market Share by Country (2020-2031)

Figure 33. U.S. Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 34. Canada Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 35. Europe Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 36. Europe Roxithromycin API Consumption Market Share by Country (2020-2031)

Figure 37. Germany Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 38. France Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 39. U.K. Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 40. Italy Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 41. Russia Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 42. Asia Pacific Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 43. Asia Pacific Roxithromycin API Consumption Market Share by Region (2020-2031)

Figure 44. China Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 45. Japan Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 46. South Korea Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 47. China Taiwan Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 48. Southeast Asia Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 49. India Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 50. Latin America, Middle East & Africa Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 51. Latin America, Middle East & Africa Roxithromycin API Consumption Market Share by Country (2020-2031)

Figure 52. Mexico Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 53. Brazil Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 54. Turkey Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 55. GCC Countries Roxithromycin API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 56. Global Production Market Share of Roxithromycin API by Type (2020-2031)

Figure 57. Global Production Value Market Share of Roxithromycin API by Type (2020-2031)

Figure 58. Global Roxithromycin API Price (US$/Kg) by Type (2020-2031)

Figure 59. Global Production Market Share of Roxithromycin API by Application (2020-2031)

Figure 60. Global Production Value Market Share of Roxithromycin API by Application (2020-2031)

Figure 61. Global Roxithromycin API Price (US$/Kg) by Application (2020-2031)

Figure 62. Roxithromycin API Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Roxithromycin API market? zhanKai

The top companies in the global Roxithromycin API market are Otto Brandes、Beijing Mesochem Technology、Century Pharmaceuticals.

Related Reports

Roxithromycin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Roxithromycin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 138
USD 3950.00
(Single User License)
Global Roxithromycin API Market Research Report 2026
The global Roxithromycin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 141
USD 2900.00
(Single User License)
Global Roxithromycin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Roxithromycin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 99
USD 4250.00
(Single User License)
Global Roxithromycin API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Roxithromycin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 153
USD 4900.00
(Single User License)
Roxithromycin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Roxithromycin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 118
USD 3950.00
(Single User License)
Global Roxithromycin API Market Research Report 2024
Roxithromycin(CAS：80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
Published Date: 2024-02-07
Pages: 104
USD 2900.00
(Single User License)

Roxithromycin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Roxithromycin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 138
USD 3950.00 (Single User License)
Global Roxithromycin API Market Research Report 2026
The global Roxithromycin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 141
USD 2900.00 (Single User License)
Global Roxithromycin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Roxithromycin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 99
USD 4250.00 (Single User License)
Global Roxithromycin API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Roxithromycin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 153
USD 4900.00 (Single User License)
Roxithromycin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Roxithromycin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 118
USD 3950.00 (Single User License)
Global Roxithromycin API Market Research Report 2024
Roxithromycin(CAS：80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
Published: 2024-02-07
Pages: 104
USD 2900.00 (Single User License)